Exhibition Recap | Harnessing the Power of Botanicals and Scientific Innovation: 2026 Shanghai HNC, FiA & CPHI Series Exhibitions

22/06/2026
Sustained Momentum: "Dual-Use" Herbs (Food & Medicine) Become the Exhibition's Key Attraction
With consumer demand for natural, healthy, and additive-free products steadily rising, the "dual-use" herb sector—rooted in Eastern wellness culture—has emerged as the standout highlight of this exhibition.
From functional foods and nutritional supplements to oral beauty products, herbal ingredients, formulations, and extracts are highly sought after. Traditional botanicals are no longer confined to simple tonic applications; they are expanding into sectors like food and beauty. Authentic herbal sources, classic formulas, and natural plant ingredients are drawing significant attention from buyers and brands alike. It is evident that leveraging millennia-old herbal heritage while innovating to meet modern consumer needs is an irreversible trend in the health and wellness industry, signaling a phase of rapid growth for the "herbal economy."
TECH-INNO Health accurately captures market trends, focusing its strategic layout on the essence of botanicals. By leveraging four major development centers, ten laboratories, and two smart manufacturing hubs—Guangdong Qingyunshan Pharmaceutical and Ganzhou Herb Green Health—the company has integrated the entire value chain, from raw material cultivation and extraction/processing to finished product manufacturing. At the exhibition, TECH-INNO Health showcased over a dozen mature herbal products, including series based on classic formulas targeting popular functional categories. This comprehensive display demonstrated the diverse application potential of herbal ingredients and offered industry partners a mature solution for modernizing traditional botanicals.
Empowering Botanicals with Craftsmanship: Technology Drives Value Upgrading for Herbal Ingredients
If botanicals form the foundation of industry development, cutting-edge technology serves as the core engine for overcoming bottlenecks and enhancing product value. The exhibition fostered a vibrant atmosphere for technical exchange, with innovations such as extraction and purification, digital-intelligent manufacturing, and ingredient activation becoming focal points of discussion. There is a broad industry consensus that technology empowers production and R&D creates differentiation.
TECH-INNO Health highlighted two proprietary technology platforms and a comprehensive process system, showcasing its robust R&D capabilities. At the event, Si Congcong (Director of the R&D Center) and Dang Xin (Director of the ODM Business Center) provided in-depth presentations on these two core technology platforms. At the same time, the exhibition showcased several cutting-edge cosmetic ingredients, such as MitoYouth® Urolithin A and SenoFis™ Fisetin. Leveraging advanced plant-based active ingredient technology, these products enable the cross-sector application of herbal raw materials, effectively breaking down the industrial barriers between food and personal care products. Numerous clients engaged in in-depth discussions regarding processing principles, technical implementation, customized solutions, and human clinical trials, garnering widespread recognition for the company's end-to-end technical service capabilities.
Key Presentation: From Pharmacopoeia to Skincare—Unlocking the Potential of Eastern Botanical Ingredients
During the exhibition, Yang Ke, Head of the Science Department, was invited to speak at the "2026 Pharmaceutical Ingredients, Technology, and Channels Empowering Beauty Industry Innovation" seminar. Delivering a presentation titled "From Pharmacopoeia to Skincare: Innovative Transformation of Eastern Botanical Functional Ingredients," Yang provided a detailed analysis of the technical pathways and regulatory compliance requirements for applying Eastern herbs to the beauty sector, offering the industry invaluable, cutting-edge insights.
Yang noted that while there is significant overlap between the hundreds of herbal ingredients listed in the *Pharmacopoeia of the People's Republic of China* and potential cosmetic ingredients, only a few—such as glycyrrhizic acid and madecassoside—have achieved mature commercial application. A vast array of high-quality resources remains trapped in an industrial "blind spot" characterized by the existence of literature but a lack of standards, data, and commercial transformation.
The presentation systematically outlined the entire process—from pharmacopoeial botanical sources to final formulation—by examining the core differences between pharmaceuticals and cosmetics, case studies of transforming classic pharmacopoeial ingredients into cosmetic components, and key technical challenges and solutions. Practical insights were shared regarding critical stages such as ingredient screening, active ingredient extraction, quality standard establishment, efficacy validation, and regulatory filing.
Qingyunshan Pharmaceutical Honored with "Leading Enterprise in Smart Manufacturing Technology Innovation" Award
During the exhibition, Qingyunshan Pharmaceutical was honored with the "Leading Enterprise in Smart Manufacturing Technology Innovation" award in recognition of its innovative achievements in smart manufacturing within the "medicine-food homology" sector.
With over 35 years of deep engagement in the health and wellness industry, Qingyunshan Pharmaceutical has consistently adhered to pharmaceutical-grade standards in the production of functional foods. By leveraging joint herbal cultivation bases at the source to ensure raw material quality and utilizing DCS-enabled intelligent online control production lines, the company achieves a fully automated, closed-loop manufacturing process. Furthermore, GMP quality management standards are integrated across the entire value chain—from harvesting and processing to quality inspection and packaging—thereby solidifying the foundation of product safety through comprehensive quality control.
The successful conclusion of the June exhibition vividly illustrates the industry's prevailing trends: the naturalization of herbal products, the technologization of production processes, and the diversification of product offerings. Traditional herbalism is revitalized through modern technology, while innovative technologies realize their value within the herbal sector; these elements complement each other, driving the "Big Health" industry toward greater sophistication and high-end development.

Participation in this exhibition served as both a showcase of achievements and a platform for in-depth industry exchange. Moving forward, TECH-INNO Health remains committed to its herbal roots, continuously upgrading its core technology platforms, expanding its portfolio of products that serve as both food and medicine, and optimizing services across the entire industry chain. The company will persist in unlocking new value in herbal products through technology and meeting market demands with high-quality offerings. By joining hands with industry peers to drive high-quality development in the "Big Health" sector, TECH-INNO Health aims to integrate the wisdom of herbal traditions into the daily lives of the general public.